Lv6
2830 积分 2022-09-24 加入
IL-17A inhibitor-induced ulcerative colitis treated with an anti-IL-23 antibody
7小时前
待确认
Case Report: Secukinumab (Interleukin-17 Inhibitor) and Ulcerative Colitis Flare - the Double-Edged Sword
7小时前
已完结
Secukinumab-induced ulcerative colitis in a patient with psoriasis successfully treated with risankizumab
7小时前
求助中
A modified Kirby-Bauer disc diffusion (mKB) method for accurately testing tigecycline susceptibility: a nation-wide multicenter comparative study
10天前
已完结
Association of Interleukin-23R Gene Polymorphisms with Behcet’s Disease Susceptibility: A Meta-Analysis of Case-control Studies
27天前
已完结
Non-HLA Genetic Polymorphisms of Interleukin-17 and Interleukin-23 Receptor in Behcet’s Syndrome
27天前
已完结
Cryptococcus
2个月前
已完结
Ixekizumab With Tirzepatide Achieved Greater Disease Control Than Ixekizumab Alone in Adults With Psoriatic Arthritis and Overweight or Obesity: Results From a Randomized Clinical Trial
2个月前
已完结
Clinical Response for 12 Months or More to the First Advanced Therapy is Associated with a Significant Decrease in the Long-Term Risk of Hospitalization: A Nation-Wide Analysis of Patients From the UK Inflammatory Bowel Disease (IBD) BioResource
3个月前
已完结
Real-World Effectiveness of and Optimization Strategies for Mirikizumab in Pediatric Ulcerative Colitis: A Prospective, Observational Study
3个月前
已完结
皖公网安备34019202002308
